Literature DB >> 21172220

Role of the T-cell interferon-gamma release assays in preventing reactivation of latent tuberculosis infection in immunosuppressed patients in treatment with anti-TNF agents.

Jose Domínguez1, Irene Latorre.   

Abstract

Entities:  

Year:  2008        PMID： 21172220     DOI： 10.1016/j.crohns.2008.05.007

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN： 1873-9946            Impact factor:   9.071


× No keyword cloud information.
  5 in total

1.  Interferon-gamma release assays in the detection of latent tuberculosis infection in patients with inflammatory arthritis scheduled for anti-tumour necrosis factor treatment.

Authors:  Sonia Mínguez; Irene Latorre; Lourdes Mateo; Alicia Lacoma; Jéssica Diaz; Alejandro Olivé; Jose Domínguez
Journal:  Clin Rheumatol       Date:  2012-01-21       Impact factor: 2.980

2.  Inflammatory bowel disease in travelers: choosing the right vaccines and check-ups.

Authors:  Maria Esteve; Carme Loras; Ester García-Planella
Journal:  World J Gastroenterol       Date:  2011-06-14       Impact factor: 5.742

3.  Dynamic QuantiFERON Response in Psoriasis Patients Taking Long-Term Biologic Therapy.

Authors:  Lorenzo Drago; Lucia Nicola; Valentina Signori; Elisa Palazzi; Cecilia Garutti; Samantha Spadino; Gianfranco Altomare
Journal:  Dermatol Ther (Heidelb)       Date:  2013-02-23

Review 4.  Impact of Host Genetics and Biological Response Modifiers on Respiratory Tract Infections.

Authors:  Alicia Lacoma; Lourdes Mateo; Ignacio Blanco; Maria J Méndez; Carlos Rodrigo; Irene Latorre; Raquel Villar-Hernandez; Jose Domínguez; Cristina Prat
Journal:  Front Immunol       Date:  2019-05-07       Impact factor: 7.561

5.  Immune-mediated inflammatory diseases differently affect IGRAs' accuracy for latent tuberculosis infection diagnosis in clinical practice.

Authors:  Irene Latorre; Sonia Mínguez; José-Manuel Carrascosa; Juan Naves; Raquel Villar-Hernández; Beatriz Muriel; Cristina Prat; Esther García-García; Irma Casas; Eugeni Domènech; Carlos Ferrándiz; Lourdes Mateo; Jose Domínguez
Journal:  PLoS One       Date:  2017-12-07       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.